ausblenden:
Schlagwörter:
Animals
Brain Neoplasms/chemistry/ genetics/ pathology
Cell Line, Tumor
Cells, Cultured
Glioma/chemistry/ genetics/ pathology
Humans
Immunophenotyping
Membrane Potentials/genetics
Mice
Neuroglia/pathology/ physiology
Tumor Cells, Cultured
Zusammenfassung:
Glioma-initiating cells (GICs) represent a potential important therapeutic target because they are likely to account for the frequent recurrence of malignant gliomas; however, their identity remains unsolved. Here, we characterized the cellular lineage fingerprint of GICs through a combination of electrophysiology, lineage marker expression, and differentiation assays of 5 human patient-derived primary GIC lines. Most GICs coexpressed nestin, NG2 proteoglycan, platelet-derived growth factor receptor-alpha, and glial fibrillary acidic protein. Glioma-initiating cells could be partially differentiated into astrocytic but not oligodendroglial or neural lineages. We also demonstrate that GICs have a characteristic electrophysiologic profile distinct from that of well-characterized tumor bulk cells. Together, our results suggest that GICs represent a unique type of cells reminiscent of an immature phenotype that closely resembles but is not identical to NG2 glia with respect to marker expression and functional membrane properties.
